|Home||» Products||» Hepatitis Drugs||» Cimivir L|
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir & Sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Dosage and Administration:
Ledipasvir & Sofosbuvir (90 mg/400 mg) is a fixed-dose combination tablet . The recommended dosage is one tablet once daily, with or without food.
- Tell your doctor or dentist that you take Ledipasvir & Sofosbuvir before you receive any medical or dental care, emergency care, or surgery.
Do not share needles, injection supplies, or items like toothbrushes or razors. Talk with your health care provider about ways to prevent the spread of HCV to others.